US Broker Ratings

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Amidst a High Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) continues to capture investor attention with its robust performance in the healthcare sector, specifically within the Diagnostics & Research industry. The Cincinnati-based clinical research organization..

DaVita Inc. (DVA) Stock Analysis: Strong Upside Potential with an 18.86% Gain on the Horizon

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector specializing in kidney dialysis services, is presenting a compelling opportunity for investors with its robust growth outlook and significant..

Medtronic plc (MDT) Stock Analysis: Unpacking a 12.94% Potential Upside with Strong Buy Ratings

Medtronic plc (NYSE: MDT), a global leader in medical devices, presents an intriguing opportunity for investors seeking stability and growth in the healthcare sector. Headquartered in Galway, Ireland, this $111.57..

Tempus AI, Inc. (TEM) Stock Analysis: 20.35% Potential Upside Amid Strong Revenue Growth

In the evolving landscape of healthcare technology, Tempus AI, Inc. (NASDAQ: TEM) stands out as a significant player, capturing investor interest with its innovative approach and strategic partnerships. With a..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 25.99% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a titan in the healthcare sector, continues to attract investor attention with its cutting-edge medical instruments and promising financial outlook. Headquartered in Sunnyvale, California, the..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Growth Potential and Dividend Stability

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is catching the eye of investors with its robust growth potential and reliable dividend yield. With a market..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring a Potential 18.16% Upside with Robust Pipeline and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) remains a compelling subject for investors interested in the healthcare sector, particularly in the realm of drug manufacturing. With a market capitalization of $165.17 billion,..

Koninklijke Philips N.V. NY Reg (PHG): Analyst Ratings Suggest 20.50% Upside Potential

Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the healthcare sector, continues to capture the attention of investors with its resilient performance and promising potential upside. As a stalwart..

Solventum Corporation (SOLV) Stock Analysis: Exploring Potential Upside with a 13.19% Gain Insight

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is making waves in the investment community with its compelling market position and strategic business segments. With a market..

Danaher Corporation (DHR) Stock Analysis: A Healthcare Giant with 11.33% Upside Potential

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, is capturing investor attention with a compelling potential upside of 11.33%, as highlighted by recent analyst ratings. With a diversified..

Insulet Corporation (PODD) Stock Analysis: Exploring a 21.77% Potential Upside in the Healthcare Sector

Insulet Corporation (NASDAQ: PODD) continues to capture the attention of investors seeking opportunities within the healthcare sector, particularly in the burgeoning field of medical devices. With a market capitalization of..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 9.14% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, offers a compelling investment opportunity with a potential upside of 9.14% based on current analyst ratings. Specializing in..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Strong Buy Ratings and Potential for Growth in Healthcare

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector with a market cap of $219.63 billion, continues to attract investors’ attention. As a leader in diagnostics and..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Innovator with a 12.53% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to captivate investor attention with its robust market presence and promising growth potential. With a market..

Quest Diagnostics (DGX) Stock Analysis: Exploring the Growth Potential in Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare diagnostics and research industry, offers a compelling investment thesis for those looking to capitalize on the growing demand for diagnostic..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Investor Outlook with a 15% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a global leader in clinical research services and healthcare intelligence, is capturing the attention of investors with its robust growth prospects and strategic market positioning...

Haleon plc (HLN) Investor Outlook: Exploring a 19.58% Potential Upside in the Healthcare Giant

Haleon plc (NYSE: HLN), a leader in the healthcare sector with a market capitalization of $44.17 billion, is capturing investor attention with its robust portfolio of consumer healthcare products and..

Stryker Corporation (SYK) Stock Analysis: Healthcare Giant Set for 12.69% Upside Potential

Stryker Corporation (NYSE: SYK) stands out in the healthcare sector as a formidable player in the medical device industry, attracting considerable attention from investors. With a market capitalization of $130.04..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring Growth Potential in Oncology with a Strong ROE

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotechnology sector, particularly within oncology, as a company committed to the discovery and development of treatments for challenging cancers. As an individual..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Strong Market Cap with High Return on Equity

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to be a focal point for investors with its impressive market capitalization of $221.79 billion. As a key player..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds